| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥373.1B | ¥409.1B | -8.8% |
| Operating Income | ¥51.8B | ¥85.2B | -39.2% |
| Ordinary Income | ¥56.9B | ¥79.5B | -28.4% |
| Net Income | ¥34.0B | ¥55.1B | -38.3% |
| ROE | 7.5% | 12.9% | - |
FY2026 Q3 results show revenue of 37.3B yen (YoY -8.8%), operating income of 5.2B yen (YoY -39.2%), ordinary income of 5.7B yen (YoY -28.4%), and net income of 3.4B yen (YoY -38.3%). Operating margin declined significantly to 13.9% from the prior year's 20.8%, reflecting weaker profitability. The company faces deteriorating working capital efficiency with cash declining 33.0% YoY to 3.1B yen despite maintaining a 229.5% current ratio. The sharp contraction in both top-line and bottom-line performance indicates fundamental operational challenges requiring immediate attention to inventory management and receivables collection.
Revenue declined 3.6B yen (-8.8%) YoY to 37.3B yen, driven by weaker demand conditions across key business segments. Segment revenue composition shows Titanium segment at 32.4B yen and High Functional Material segment at 4.9B yen. Gross profit was 9.6B yen with a gross margin of 25.7%, declining from prior year levels. Operating profit fell 3.3B yen (-39.2%) to 5.2B yen, primarily driven by the combination of revenue decline and elevated SG&A expenses of 4.4B yen, which increased as a percentage of sales and created negative operating leverage. Operating margin compression of approximately 6.9 percentage points indicates significant cost structure challenges. Non-operating income contributed a net positive of 0.5B yen (non-operating income 0.8B yen minus non-operating expenses 0.3B yen), with foreign exchange losses of 0.7B yen partially offset by foreign exchange gains of 0.4B yen, resulting in ordinary income of 5.7B yen. The gap between ordinary income of 5.7B yen and net income of 3.4B yen (40% difference) reflects the impact of non-recurring factors including extraordinary losses of 0.8B yen from fixed asset disposals, which represented 23.2% of net income. Income tax expenses of 1.5B yen resulted in an effective tax rate of approximately 30.7%. This represents a revenue down/profit down pattern, with profitability declining at a faster rate than revenue due to fixed cost deleveraging and one-time impairments.
Titanium segment generated revenue of 32.4B yen with operating income of 4.1B yen, representing an operating margin of 12.7%. This constitutes the core business at approximately 87% of total segment sales. High Functional Material segment recorded revenue of 4.9B yen with operating income of 1.1B yen, achieving a higher operating margin of 21.6%. The margin differential of 8.9 percentage points between segments indicates that High Functional Material maintains superior profitability despite its smaller scale, while the Titanium segment's lower margin reflects competitive pressure or operational inefficiencies. The consolidated segment operating income totals 5.2B yen, which equals the company's reported operating income with no reconciliation differences.
[Profitability] ROE of 7.5% remains below the manufacturing industry median of 5.2% (2025-Q3) but has declined from stronger prior year performance. Operating margin of 13.9% exceeds the industry median of 8.7%, while net profit margin of 9.1% also exceeds the industry median of 6.4%, indicating relatively strong profitability positioning despite YoY deterioration. However, ROA of 3.1% aligns closely with the industry median of 3.3%, and ROIC of 3.9% falls below the industry median of 6.0%, suggesting capital efficiency challenges. [Cash Quality] Cash and equivalents of 3.1B yen provide coverage of 0.16 times short-term debt, significantly below healthy levels and indicating immediate liquidity concerns despite total current assets of 43.4B yen against current liabilities of 18.9B yen. [Investment Efficiency] Asset turnover of 0.346 trails the industry median of 0.58, reflecting underutilization of the asset base of 107.9B yen. Working capital cycle metrics show severe inefficiency with receivables turnover of 263 days versus industry median of 83 days, inventory turnover of 475 days versus industry median of 109 days, and payables turnover of 73 days versus industry median of 56 days, resulting in a cash conversion cycle of 665 days versus industry median of 108 days. [Financial Health] Equity ratio of 41.8% falls below the industry median of 63.8%, indicating higher leverage. Current ratio of 229.5% and quick ratio of 165.4% exceed industry medians, but cash coverage remains critically low. Debt-to-equity ratio of 1.09 reflects elevated leverage with total interest-bearing debt of 49.1B yen split between short-term borrowings of 18.9B yen and long-term debt of 30.2B yen. Financial leverage of 2.39 times exceeds the industry median of 1.53 times, amplifying both returns and risks.
Cash and deposits decreased 1.5B yen (-33.0%) YoY to 3.1B yen, representing a significant deterioration in liquidity position. The substantial working capital buildup with accounts receivable of 26.8B yen and inventories of 18.5B yen absorbed considerable cash resources. The working capital cycle extended to 665 days, far exceeding efficient operating norms and indicating cash trapped in operations. Despite quarterly net income of 3.4B yen, cash declined materially, suggesting negative operating cash flow characteristics driven by rising receivables and inventory. Short-term borrowings of 18.9B yen increased to support working capital needs, evidencing external financing dependence. The cash coverage of short-term liabilities at 0.16 times indicates structural liquidity stress requiring urgent management attention. Interest coverage ratio of 22.5 times based on operating profit provides some buffer, but the combination of elevated debt service obligations and constrained cash generation creates refinancing risk.
Ordinary income of 5.7B yen versus operating income of 5.2B yen reflects a modest non-operating net contribution of approximately 0.5B yen. Non-operating items include foreign exchange impacts with gross gains of 0.4B yen offset by losses of 0.7B yen, resulting in net foreign exchange losses. Non-operating income represents approximately 2.1% of revenue, indicating limited reliance on financial income or equity method gains for earnings. The most significant earnings quality concern stems from extraordinary losses of 0.8B yen from fixed asset disposals, which reduced net income by 23.2% and represents a material non-recurring factor. The gap between reported earnings and underlying operational performance is substantial. Operating cash flow data is not available for quarterly reporting, limiting direct assessment of accruals quality, but the material decline in cash position despite positive accounting earnings suggests negative accruals and potential earnings quality concerns. The combination of one-time impairments and working capital deterioration indicates that reported net income overstates sustainable cash-generating capacity.
Full-year guidance projects revenue of 46.0B yen (YoY -11.4%), operating income of 4.8B yen (YoY -52.4%), ordinary income of 5.1B yen (YoY -43.8%), and net income of 2.2B yen (YoY -69.0%). Q3 cumulative results show revenue progress rate of 81.1%, operating income progress rate of 107.9%, ordinary income progress rate of 111.6%, and net income progress rate of 154.5% against full-year targets. Operating income and above have already exceeded full-year guidance by Q3, indicating conservative full-year assumptions or expectation of Q4 losses. Revenue progress of 81.1% at Q3 (versus standard 75%) suggests relatively on-track top-line performance, but profit guidance implies significant Q4 deterioration is anticipated. The company has revised guidance downward with YoY declines across all metrics, reflecting fundamental business headwinds. The disconnect between strong Q3 cumulative profit achievement versus full-year targets suggests management expects material Q4 charges, seasonal weakness, or further operational deterioration in the final quarter.
Annual dividend is set at 10.0 yen per share based on full-year forecast data. Comparing against net income guidance of 2.2B yen for the full year and approximately 36.8 million shares outstanding, the payout ratio calculates to approximately 16.7%, indicating conservative shareholder returns relative to earnings. Actual Q3 cumulative net income of 3.4B yen against the same share base would imply a payout ratio of 10.8% if applied to year-to-date results. The reduced dividend level reflects management's cautious stance given cash flow constraints, with cash declining 33.0% YoY and elevated working capital absorption. No share buyback activities are disclosed in the available data. The total return ratio equals the payout ratio at approximately 16.7% in the absence of buybacks, indicating significant retained earnings for either reinvestment or balance sheet preservation. Given liquidity pressures evidenced by cash coverage of only 0.16 times short-term debt, the conservative payout approach appears prudent to maintain financial flexibility.
Working capital deterioration risk remains the most critical factor with cash conversion cycle extending to 665 days, approximately 6 times the industry median of 108 days. Receivables of 26.8B yen aging at 263 days and inventory of 18.5B yen turning at 475 days create substantial liquidity strain. Should collection or inventory liquidation face further delays, cash position could deteriorate to critical levels. Short-term refinancing risk stems from 18.9B yen of short-term borrowings against only 3.1B yen of cash. The debt maturity profile with 38.5% in short-term obligations creates rollover risk if lender confidence deteriorates or credit conditions tighten. Operating leverage risk is evident from the 39.2% operating profit decline on 8.8% revenue decline, demonstrating a 4.4x negative operating leverage ratio. Fixed cost structure combined with demand weakness means incremental revenue losses produce disproportionate profit impacts. SG&A expenses of 4.4B yen represent 11.8% of sales, and if demand continues declining without corresponding cost reduction, margins will face further compression.
[Industry Position] (Reference - Proprietary Analysis) The company demonstrates above-median profitability metrics but faces significant efficiency and leverage challenges relative to manufacturing industry peers. Profitability positioning shows operating margin of 13.9% substantially exceeds the industry median of 8.7% (2025-Q3, n=100), and net profit margin of 9.1% exceeds the industry median of 6.4%, indicating superior pricing power or cost management versus typical manufacturers. ROE of 7.5% exceeds the industry median of 5.2%, though elevated financial leverage of 2.39x versus median 1.53x contributes to this differential. Efficiency metrics reveal material underperformance with asset turnover of 0.35 significantly lagging the industry median of 0.58, indicating 40% lower asset productivity. Working capital efficiency represents the most severe divergence with receivables at 263 days versus median 83 days (3.2x longer), inventory at 475 days versus median 109 days (4.4x longer), and payables at 73 days versus median 56 days, combining for a cash conversion cycle of 665 days versus median 108 days. This represents over 6x industry-standard working capital intensity. Financial health metrics show equity ratio of 41.8% well below the industry median of 63.8%, indicating higher leverage risk. Current ratio of 229.5% exceeds typical manufacturing companies but masks the critical cash/short-term debt coverage weakness. The company operates with structural working capital inefficiency that distinguishes it negatively from industry peers, while maintaining compensating profitability advantages that partially offset operational challenges. Revenue decline of 8.8% versus industry median growth of 2.8% indicates company-specific demand or market share pressures beyond sector trends.
Working capital inefficiency represents the dominant financial characteristic requiring immediate remediation, with 665-day cash conversion cycle absorbing substantial capital and creating liquidity stress evidenced by 33% cash decline and heavy short-term borrowing dependence. The extreme divergence from industry norms (6x median working capital cycle) indicates either industry-specific characteristics not captured in broader manufacturing comparisons, or company-specific operational challenges in collections and inventory management. Profitability sustainability faces pressure from operating leverage dynamics, where 8.8% revenue decline produced 39.2% operating profit decline, indicating 4.4x negative leverage that could accelerate further if demand weakness continues. Q4 guidance implies significant deterioration versus Q3 run-rate performance with full-year profit targets already exceeded through Q3, suggesting management anticipates material charges, writedowns, or seasonal weakness ahead. The combination of superior margins (13.9% operating margin versus 8.7% industry median) with inferior asset efficiency (0.35x turnover versus 0.58x median) creates a strategic crossroads between defending profitability through pricing discipline while risking further volume loss, or pursuing volume recovery through margin sacrifice.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.